المؤلفون: Philippe Armand, John M. Timmerman, Alexander M. Lesokhin, Ivan Borrello, Mihaela Popa McKiver, Lili Zhu, Stephen M. Ansell, Martin Gutierrez

المصدر: Leukemia

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Lymphoma, Programmed Cell Death 1 Receptor, Salvage therapy, Ipilimumab, Article, Young Adult, Alkaloids, Receptors, KIR, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, CTLA-4 Antigen, Survival rate, Multiple myeloma, Aged, Aged, 80 and over, Salvage Therapy, business.industry, Lymphoma, Non-Hodgkin, Hematology, Middle Aged, medicine.disease, Prognosis, Hodgkin Disease, Blockade, Survival Rate, Nivolumab, Tolerability, Drug Resistance, Neoplasm, Female, Neoplasm Recurrence, Local, business, Multiple Myeloma, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dea15b8905ec241a20d6013080a1e39aTest
https://pubmed.ncbi.nlm.nih.gov/32601377Test

المؤلفون: Karin Tarte, Thomas E. Witzig, Imane Azzaoui, Thomas M. Habermann, Andrew L. Feldman, Céline Pangault, Noel Milpied, Stephen M. Ansell, Thierry Fest, Marie Parrens, Matthew J. Maurer, James R. Cerhan, Delphine Rossille, Mikael Roussel, Susan L. Slager, Thierry Lamy, Gaëlle Labouré, Brian K. Link

المساهمون: Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], Mayo Clinic [Rochester], CHU Bordeaux [Bordeaux], University of Iowa [Iowa City], This study is supported by the French Health Minister (BMS_LyTrans project, NCT01287923), the National Institute of Cancer (INCa Translational Research 2010), the French Lymphoma Study Association (LYSA), the French National Agency for Research (ANR Carnot/CALYM), the National Cancer Institute (P50 CA97274, R01 CA92153), and the Henry J Predolin Foundation. Concerning the French cohort, we are indebted to the LYSA pathology platform (Hôpital Henri Mondor, Créteil) for immunohistochemical experiments, the Centre de Ressources Biologiques CRB-Santé (BB-0033-00056) of the Rennes hospital for providing high quality samples. This work was partly supported by a French National Cancer Institute post-doctoral fellowship (grant number PDOC-RC-GO/07-003) to the first author (D.R.)., Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Chard-Hutchinson, Xavier

المصدر: Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩
Leukemia, 2017, 31 (4), pp.988-991. ⟨10.1038/leu.2016.385⟩

مصطلحات موضوعية: Adult, Male, [SDV.MHEP.HEM] Life Sciences [q-bio]/Human health and pathology/Hematology, Cancer Research, medicine.medical_specialty, Adolescent, Programmed Cell Death 1 Receptor, [SDV.CAN]Life Sciences [q-bio]/Cancer, Article, Young Adult, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Refractory, immune system diseases, hemic and lymphatic diseases, Internal medicine, Biomarkers, Tumor, Tumor Microenvironment, medicine, Humans, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, Hematology, business.industry, Peripheral tolerance, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Middle Aged, Prognosis, medicine.disease, 3. Good health, Lymphoma, Leukemia, Oncology, Apoptosis, 030220 oncology & carcinogenesis, Immunology, Cancer research, Female, Rituximab, Lymphoma, Large B-Cell, Diffuse, business, Diffuse large B-cell lymphoma, 030215 immunology, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a0877267aca814536e5a4718fd95531Test
https://doi.org/10.1038/leu.2016.385Test

المؤلفون: Carlos Bueso-Ramos, Masoud Davanlou, Courtney D. DiNardo, Sherry Pierce, Hui Yang, Marcos R. Estecio, Guillermo Garcia-Manero, Yue Wei, Hagop M. Kantarjian, Qi-Rong Geng, Jorge E. Cortes, Simrit Parmar, Martin Nguyen, Zhihong Fang

المصدر: Leukemia

مصطلحات موضوعية: Adult, Male, Cancer Research, Antimetabolites, Antineoplastic, Myeloid, Programmed Cell Death 1 Ligand 2 Protein, Azacitidine, Programmed Cell Death 1 Receptor, Decitabine, Chronic myelomonocytic leukemia, Biology, Real-Time Polymerase Chain Reaction, Article, B7-H1 Antigen, Cohort Studies, Immunoenzyme Techniques, hemic and lymphatic diseases, medicine, Biomarkers, Tumor, Tumor Cells, Cultured, Humans, CTLA-4 Antigen, RNA, Messenger, programmed death-1, Aged, Aged, 80 and over, DNA methylation, Reverse Transcriptase Polymerase Chain Reaction, Myelodysplastic syndromes, Myeloid leukemia, Leukemia, Myelomonocytic, Chronic, Hematology, Middle Aged, medicine.disease, Flow Cytometry, Prognosis, myelodysplastic syndromes, Survival Rate, Leukemia, Leukemia, Myeloid, Acute, medicine.anatomical_structure, Oncology, Immunology, Leukocytes, Mononuclear, Female, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b303b46f2fe044017ea2b795c1a76f0Test
http://europepmc.org/articles/PMC4032802Test